NIH-funded research R03 grant

Understanding how Black ancestry affects colorectal cancer biology

Official title: Disentangling the effect of Black/African Ancestry from confounding variables on colorectal cancer biology

Funded at State University New York Stony Brook · NIH-11070390 · Data updated 2026-11-12

This study is looking at how colorectal cancer might be different in people of Black African ancestry compared to those of White European ancestry, hoping to find clues that could lead to better, more personalized treatments for everyone.

More Colorectal Cancer research and trials

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionState University New York Stony Brook
NIH-funded
Lab location1 site (Stony Brook, United States)
Project startApril 8, 2024
Project endMarch 31, 2026
Funding year2025
Award (this year)$79,245
NIH project number5R03CA283359-02
Project IDNIH-11070390 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who self-identify as Black or of African ancestry and have been diagnosed with colorectal cancer.

Less likely to help

Patients who do not identify as Black or of African ancestry may not receive direct benefits from this research.

What this research studies

This research investigates the biological differences in colorectal cancer (CRC) between individuals of Black African ancestry and those of White European ancestry. By analyzing a large collection of archived tissue samples, the study aims to identify specific gene expression differences that may contribute to the higher incidence and mortality rates of CRC in Black individuals. The research will utilize advanced bioinformatics and multi-disciplinary approaches to disentangle the effects of ancestry from other confounding factors. Patients may benefit from a better understanding of how their ancestry influences cancer biology, potentially leading to more tailored treatment options.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment strategies for colorectal cancer in patients of Black ancestry.

How similar studies have gone: Previous studies have shown significant differences in gene expression related to race in colorectal cancer, indicating that this research builds on established findings but aims to expand the sample size and understanding.

Where this research is happening

  • State University New York Stony Brook
    Stony Brook, United States
    Active

Researchers

  • Principal investigator: Guillaume, Alexandra — State University New York Stony Brook
  • Study coordinator: Guillaume, Alexandra

Related research

Other NIH-funded projects on the same topics.

  • Improving colorectal cancer screening and follow-up care.

    This study is working to help more people get screened for colorectal cancer and receive the follow-up care they need, especially those who haven't been screened much before, so that everyone can have better access to important health checks and improve their overall health.

    NIH research Research Triangle Institute · Research Triangle Park, United States · NIH-9627071

  • Colorectal cancer prognosis through a broad, collaborative study

    A large, multi-center study follows people newly diagnosed with colorectal cancer to find biomarkers and patterns that predict outcomes and guide future care.

    NIH research Utah State Higher Education System--University of Utah · Salt Lake City, United States · NIH-11590756

  • Ceramides and how they affect metabolism and colorectal cancer in adults

    A study in adults with obesity-related health issues will explore how a fat-related molecule called ceramide influences metabolic problems and colorectal cancer risk.

    NIH research Utah State Higher Education System--University of Utah · Salt Lake City, United States · NIH-11535283

  • Automated point-of-care DNA methylation test for colorectal cancer in LMICs

    A fast, affordable blood test using DNA markers to help identify people at higher risk of colorectal cancer in low- and middle-income countries.

    NIH research Johns Hopkins University · Baltimore, United States · NIH-11531863

  • Rewiring Colorectal Cancer to Harness Therapeutic Hyperactivation

    A Yale team is exploring brain-storming new ways to treat colorectal cancer by safely boosting certain cancer signaling pathways to kill cancer cells and by reshaping cancer cell states to improve responses to existing therapies.

    NIH research Yale University · New Haven, United States · NIH-11505210

  • Comparative modeling to guide colorectal cancer screening and care

    A researcher team will use computer models to study how access to care, risk, and new screening options affect colorectal cancer outcomes and costs for adults in the US.

    NIH research Utah State Higher Education System--University of Utah · Salt Lake City, United States · NIH-11495363

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.